ABF Analytisch-Biologisches Forschungslabor GmbH is a startup based in Germany.
ABF is an ISO 17025-accredited and GLP/ GCP-compliant bioanalytical contract research laboratory in Germany that develops and applies validated LC-MS and GC-MS methods for biomarker analysis, biomonitoring, DMPK, tobacco harm reduction and cannabinoid bioanalysis to support (pre)clinical, epidemiological and regulatory studies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.